Cholestadienols
"Cholestadienols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.
| Descriptor ID |
D002775
|
| MeSH Number(s) |
D04.210.500.247.222.222.347
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholestadienols".
Below are MeSH descriptors whose meaning is more specific than "Cholestadienols".
This graph shows the total number of publications written about "Cholestadienols" by people in this website by year, and whether "Cholestadienols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholestadienols" by people in Profiles.
-
Merris M, Kraeft J, Tint GS, Lenard J. Long-term effects of sterol depletion in C. elegans: sterol content of synchronized wild-type and mutant populations. J Lipid Res. 2004 Nov; 45(11):2044-51.
-
Tint GS, Abuelo D, Till M, Cordier MP, Batta AK, Shefer S, Honda A, Honda M, Xu G, Irons M, Elias ER, Salen G. Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Prenat Diagn. 1998 Jul; 18(7):651-8.
-
Tint GS, Batta AK, Xu G, Shefer S, Honda A, Irons M, Elias ER, Salen G. The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis. Subcell Biochem. 1997; 28:117-44.